Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1373533생성일: 2026년 10월 26일
Sodium triacetoxyborohydride → 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one
https://huagongshe.com/reaction/1373533
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium triacetoxyborohydride | HCID 5049666 | — |
| 반응물 | 1-(5-Chloro-2-isopropoxy-phenyl)-piperazine | HCID 21073166 | — |
| 반응물 | 4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanal | HCID 21073377 | — |
| 용매 | 1,1-Dichloroethane | HCID 6365 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one | HCID 21073711 | 45.4% |
반응 단계
To a suspension of 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.241 g, 1.02 mmol, 1 eq) and 1-(5-chloro-2-isopropoxy-phenyl)-piperazine (0.382 g, 1.13 mmol, 1.1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.583 g, 2.75 mmol, 2.67 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with EtOAc and quenched with saturated NaHCO3. The organic phase was then washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (100% EtOAc) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.219 g, 25%). MS: APCI: M+1: 473.2 (Exact Mass: 472.22).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07160888B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_01 |
|---|
| ORD ID | ord-dd37439ed99643c7a02d08a9e358a307 |
|---|
| 출처 메모 | uspto-grants-2007_01 |
|---|